SER SERINA THERAPEUTICS INC Management Changes 8-K Filing 2023 - Annual Meeting of Stockholders AgeX Therapeutics held its 2023 annual meeting of stockholders, where three directors were elected, the appointment of WithumSmith + Brown PC as independent registered public accountants was ratified, and a proposal to permit Juvenescence Limited to acquire additional shares of AgeX common stock was approved.Get access to all SEC 8-K filings of the SERINA THERAPEUTICS INC